Ronghua Yan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ronghua Yan has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Erjiao Xu
Department of Medical Ultrasonics, The Eighth Affiliated Hospital of Sun Yat-Sen University, Shenzhen, China
6 shared publications Huahui Liu
Department of Medical Ultrasonics, The Eighth Affiliated Hospital of Sun Yat-sen University, No. 3025 Shennan Middle Road, Futian Street, Futian District, Shenzhen, Guangdong Province, PR China
5 shared publicationsSainan Guan
Department of Medical Ultrasonics, The Eighth Affiliated Hospital of Sun Yat-sen University, No. 3025 Shennan Middle Road, Futian Street, Futian District, Shenzhen, Guangdong Province, PR China
5 shared publicationsShuang Liang
Department of Medical Ultrasonics, The Eighth Affiliated Hospital of Sun Yat-sen University, No. 3025 Shennan Middle Road, Futian Street, Futian District, Shenzhen, Guangdong Province, PR China
5 shared publicationsHaiyu Kang
Department of Medical Ultrasonics, The Eighth Affiliated Hospital of Sun Yat-sen University, No. 3025 Shennan Middle Road, Futian Street, Futian District, Shenzhen, Guangdong Province, PR China
3 shared publicationsLiping Luo
Department of Medical Ultrasonics, The Eighth Affiliated Hospital of Sun Yat-sen University, No. 3025 Shennan Middle Road, Futian Street, Futian District, Shenzhen, Guangdong Province, PR China
3 shared publications
Latest Publications
- Open Access
- 25 December 2025
- Published by JMIR Publications Inc. in JMIR Medical Informatics
- Vol. 13, e80182
Performance of ChatGPT-4o, Claude 3 Opus, and DeepSeek-R1 in BI-RADS Category 4 Classification and Malignancy Prediction From Mammography Reports: Retrospective Diagnostic Study
Background: Mammography is a key imaging modality for breast cancer screening and diagnosis, with the Breast Imaging Reporting and Data System (BI-RADS) providing standardized risk stratification. However, BI-RADS category 4 lesions pose a diagnostic challenge due to their wide malignancy probability range and substantial overlap between benign and malignant findings. Moreover, current interpretations rely heavily on radiologists’ expertise, leading to variability and potential diagnostic errors. Recent advances in large language models (LLMs), such as ChatGPT-4o, Claude 3 Opus, and DeepSeek-R1, offer new possibilities for automated medical report interpretation. Objective: This study aims to explore the feasibility of LLMs in evaluating the benign or malignant subcategories of BI-RADS category 4 lesions based on free-text mammography reports. Methods: This retrospective, single-center study included 307 patients (mean age 47.25, 11.39 years) with BI-RADS category 4 mammography reports between May 2021 and March 2024. Three LLMs (ChatGPT-4o, Claude 3 Opus, and DeepSeek-R1) classified BI-RADS 4 subcategories from the reports’ text only, whereas radiologists based their classifications on image review. Pathology served as the reference standard, and the reproducibility of LLMs’ predictions was assessed. The diagnostic performance of radiologists and LLMs was compared, and the internal reasoning behind LLMs’ misclassifications was analyzed. Results: ChatGPT-4o demonstrated higher reproducibility than DeepSeek-R1 and Claude 3 Opus (Fleiss κ 0.850 vs 0.824 and 0.732, respectively). Although the overall accuracy of LLMs was lower than that of radiologists (senior: 74.5%; junior: 72.0%; DeepSeek-R1: 63.5%; ChatGPT-4o: 62.4%; Claude 3 Opus: 60.8%), their sensitivity was higher (senior: 80.7%; junior: 68.0%; DeepSeek-R1: 84.0%; ChatGPT-4o: 84.7%; Claude 3 Opus: 92.7%), while specificity remained lower (senior: 68.3%; junior: 76.1%; DeepSeek-R1: 43.0%; ChatGPT-4o: 40.1%; Claude 3 Opus: 28.9%). DeepSeek-R1 achieved the best prediction accuracy among LLMs with an area under the receiver operating characteristic curve of 0.64 (95% CI 0.57-0.70), followed by ChatGPT-4o (0.62, 95% CI 0.56-0.69) and Claude 3 Opus (0.61, 95% CI 0.54-0.67). By comparison, junior and senior radiologists achieved higher area under the receiver operating characteristic curves of 0.72 (95% CI 0.66-0.78) and 0.75 (95% CI 0.69-0.80), respectively. DeLong testing confirmed that all three LLMs performed significantly worse than both junior and senior radiologists (all P<.05), and no significant difference was observed between the two radiologist groups (P=.55). At the subcategory level, ChatGPT-4o yielded an overall F1-score of 47.6%, DeepSeek-R1 achieved 45.6%, and Claude 3 Opus achieved 36.2%. Conclusions: LLMs are feasible for distinguishing between benign and malignant lesions in BI-RADS category 4, with good stability and high sensitivity, but relatively insufficient specificity. They show potential in screening and may assist radiologists in reducing missed diagnoses.
- 25 December 2025
- Published by JMIR Publications Inc. in JMIR Medical Informatics
- Vol. 13, e80182
Open AccessPerformance of ChatGPT-4o, Claude 3 Opus, and DeepSeek-R1 in BI-RADS Category 4 Classification and Malignancy Prediction From Mammography Reports: Retrospective Diagnostic Study
Background: Mammography is a key imaging modality for breast cancer screening and diagnosis, with the Breast Imaging Reporting and Data System (BI-RADS) providing standardized risk stratification. However, BI-RADS category 4 lesions pose a diagnostic challenge due to their wide malignancy probability range and substantial overlap between benign and malignant findings. Moreover, current interpretations rely heavily on radiologists’ expertise, leading to variability and potential diagnostic errors. Recent advances in large language models (LLMs), such as ChatGPT-4o, Claude 3 Opus, and DeepSeek-R1, offer new possibilities for automated medical report interpretation. Objective: This study aims to explore the feasibility of LLMs in evaluating the benign or malignant subcategories of BI-RADS category 4 lesions based on free-text mammography reports. Methods: This retrospective, single-center study included 307 patients (mean age 47.25, 11.39 years) with BI-RADS category 4 mammography reports between May 2021 and March 2024. Three LLMs (ChatGPT-4o, Claude 3 Opus, and DeepSeek-R1) classified BI-RADS 4 subcategories from the reports’ text only, whereas radiologists based their classifications on image review. Pathology served as the reference standard, and the reproducibility of LLMs’ predictions was assessed. The diagnostic performance of radiologists and LLMs was compared, and the internal reasoning behind LLMs’ misclassifications was analyzed. Results: ChatGPT-4o demonstrated higher reproducibility than DeepSeek-R1 and Claude 3 Opus (Fleiss κ 0.850 vs 0.824 and 0.732, respectively). Although the overall accuracy of LLMs was lower than that of radiologists (senior: 74.5%; junior: 72.0%; DeepSeek-R1: 63.5%; ChatGPT-4o: 62.4%; Claude 3 Opus: 60.8%), their sensitivity was higher (senior: 80.7%; junior: 68.0%; DeepSeek-R1: 84.0%; ChatGPT-4o: 84.7%; Claude 3 Opus: 92.7%), while specificity remained lower (senior: 68.3%; junior: 76.1%; DeepSeek-R1: 43.0%; ChatGPT-4o: 40.1%; Claude 3 Opus: 28.9%). DeepSeek-R1 achieved the best prediction accuracy among LLMs with an area under the receiver operating characteristic curve of 0.64 (95% CI 0.57-0.70), followed by ChatGPT-4o (0.62, 95% CI 0.56-0.69) and Claude 3 Opus (0.61, 95% CI 0.54-0.67). By comparison, junior and senior radiologists achieved higher area under the receiver operating characteristic curves of 0.72 (95% CI 0.66-0.78) and 0.75 (95% CI 0.69-0.80), respectively. DeLong testing confirmed that all three LLMs performed significantly worse than both junior and senior radiologists (all P<.05), and no significant difference was observed between the two radiologist groups (P=.55). At the subcategory level, ChatGPT-4o yielded an overall F1-score of 47.6%, DeepSeek-R1 achieved 45.6%, and Claude 3 Opus achieved 36.2%. Conclusions: LLMs are feasible for distinguishing between benign and malignant lesions in BI-RADS category 4, with good stability and high sensitivity, but relatively insufficient specificity. They show potential in screening and may assist radiologists in reducing missed diagnoses.
- 2 December 2025
- Published by Elsevier in European Journal of Radiology
- Vol. 195, 112597
Application of three ablative margin assessment techniques for hepatocellular carcinoma in clinical practice: a comparative study
- 2 December 2025
- Published by Elsevier in European Journal of Radiology
- Vol. 195, 112597
Application of three ablative margin assessment techniques for hepatocellular carcinoma in clinical practice: a comparative study
- Open Access
- 6 July 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Performance of ChatGPT-4o, Claude 3 Opus, and DeepSeek-R1 in BI-RADS Category 4 Classification and Malignancy Prediction From Mammography Reports: Retrospective Diagnostic Study (Preprint)
BACKGROUND Mammography is a key imaging modality for breast cancer screening and diagnosis, with the Breast Imaging Reporting and Data System (BI-RADS) providing standardized risk stratification. However, BI-RADS category 4 lesions pose a diagnostic challenge due to their wide malignancy probability range and substantial overlap between benign and malignant findings. Moreover, current interpretations rely heavily on radiologists’ expertise, leading to variability and potential diagnostic errors. Recent advances in large language models (LLMs), such as ChatGPT-4o, Claude 3 Opus, and DeepSeek-R1, offer new possibilities for automated medical report interpretation. OBJECTIVE This study aims to explore the feasibility of LLMs in evaluating the benign or malignant subcategories of BI-RADS category 4 lesions based on free-text mammography reports. METHODS This retrospective, single-center study included 307 patients (mean age 47.25, 11.39 years) with BI-RADS category 4 mammography reports between May 2021 and March 2024. Three LLMs (ChatGPT-4o, Claude 3 Opus, and DeepSeek-R1) classified BI-RADS 4 subcategories from the reports’ text only, whereas radiologists based their classifications on image review. Pathology served as the reference standard, and the reproducibility of LLMs’ predictions was assessed. The diagnostic performance of radiologists and LLMs was compared, and the internal reasoning behind LLMs’ misclassifications was analyzed. RESULTS ChatGPT-4o demonstrated higher reproducibility than DeepSeek-R1 and Claude 3 Opus (Fleiss κ 0.850 vs 0.824 and 0.732, respectively). Although the overall accuracy of LLMs was lower than that of radiologists (senior: 74.5%; junior: 72.0%; DeepSeek-R1: 63.5%; ChatGPT-4o: 62.4%; Claude 3 Opus: 60.8%), their sensitivity was higher (senior: 80.7%; junior: 68.0%; DeepSeek-R1: 84.0%; ChatGPT-4o: 84.7%; Claude 3 Opus: 92.7%), while specificity remained lower (senior: 68.3%; junior: 76.1%; DeepSeek-R1: 43.0%; ChatGPT-4o: 40.1%; Claude 3 Opus: 28.9%). DeepSeek-R1 achieved the best prediction accuracy among LLMs with an area under the receiver operating characteristic curve of 0.64 (95% CI 0.57-0.70), followed by ChatGPT-4o (0.62, 95% CI 0.56-0.69) and Claude 3 Opus (0.61, 95% CI 0.54-0.67). By comparison, junior and senior radiologists achieved higher area under the receiver operating characteristic curves of 0.72 (95% CI 0.66-0.78) and 0.75 (95% CI 0.69-0.80), respectively. DeLong testing confirmed that all three LLMs performed significantly worse than both junior and senior radiologists (all P<.05), and no significant difference was observed between the two radiologist groups (P=.55). At the subcategory level, ChatGPT-4o yielded an overall F1-score of 47.6%, DeepSeek-R1 achieved 45.6%, and Claude 3 Opus achieved 36.2%. CONCLUSIONS LLMs are feasible for distinguishing between benign and malignant lesions in BI-RADS category 4, with good stability and high sensitivity, but relatively insufficient specificity. They show potential in screening and may assist radiologists in reducing missed diagnoses.
- 6 July 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessPerformance of ChatGPT-4o, Claude 3 Opus, and DeepSeek-R1 in BI-RADS Category 4 Classification and Malignancy Prediction From Mammography Reports: Retrospective Diagnostic Study (Preprint)
BACKGROUND Mammography is a key imaging modality for breast cancer screening and diagnosis, with the Breast Imaging Reporting and Data System (BI-RADS) providing standardized risk stratification. However, BI-RADS category 4 lesions pose a diagnostic challenge due to their wide malignancy probability range and substantial overlap between benign and malignant findings. Moreover, current interpretations rely heavily on radiologists’ expertise, leading to variability and potential diagnostic errors. Recent advances in large language models (LLMs), such as ChatGPT-4o, Claude 3 Opus, and DeepSeek-R1, offer new possibilities for automated medical report interpretation. OBJECTIVE This study aims to explore the feasibility of LLMs in evaluating the benign or malignant subcategories of BI-RADS category 4 lesions based on free-text mammography reports. METHODS This retrospective, single-center study included 307 patients (mean age 47.25, 11.39 years) with BI-RADS category 4 mammography reports between May 2021 and March 2024. Three LLMs (ChatGPT-4o, Claude 3 Opus, and DeepSeek-R1) classified BI-RADS 4 subcategories from the reports’ text only, whereas radiologists based their classifications on image review. Pathology served as the reference standard, and the reproducibility of LLMs’ predictions was assessed. The diagnostic performance of radiologists and LLMs was compared, and the internal reasoning behind LLMs’ misclassifications was analyzed. RESULTS ChatGPT-4o demonstrated higher reproducibility than DeepSeek-R1 and Claude 3 Opus (Fleiss κ 0.850 vs 0.824 and 0.732, respectively). Although the overall accuracy of LLMs was lower than that of radiologists (senior: 74.5%; junior: 72.0%; DeepSeek-R1: 63.5%; ChatGPT-4o: 62.4%; Claude 3 Opus: 60.8%), their sensitivity was higher (senior: 80.7%; junior: 68.0%; DeepSeek-R1: 84.0%; ChatGPT-4o: 84.7%; Claude 3 Opus: 92.7%), while specificity remained lower (senior: 68.3%; junior: 76.1%; DeepSeek-R1: 43.0%; ChatGPT-4o: 40.1%; Claude 3 Opus: 28.9%). DeepSeek-R1 achieved the best prediction accuracy among LLMs with an area under the receiver operating characteristic curve of 0.64 (95% CI 0.57-0.70), followed by ChatGPT-4o (0.62, 95% CI 0.56-0.69) and Claude 3 Opus (0.61, 95% CI 0.54-0.67). By comparison, junior and senior radiologists achieved higher area under the receiver operating characteristic curves of 0.72 (95% CI 0.66-0.78) and 0.75 (95% CI 0.69-0.80), respectively. DeLong testing confirmed that all three LLMs performed significantly worse than both junior and senior radiologists (all P<.05), and no significant difference was observed between the two radiologist groups (P=.55). At the subcategory level, ChatGPT-4o yielded an overall F1-score of 47.6%, DeepSeek-R1 achieved 45.6%, and Claude 3 Opus achieved 36.2%. CONCLUSIONS LLMs are feasible for distinguishing between benign and malignant lesions in BI-RADS category 4, with good stability and high sensitivity, but relatively insufficient specificity. They show potential in screening and may assist radiologists in reducing missed diagnoses.
- 30 November 2024
- Published by Springer Nature in Abdominal Radiology
- Vol. 50 (6) , 2512-2521
Intelligent automatic registration: is it feasible and efficient for application of ultrasound fusion imaging in liver?
Purpose To evaluate the feasibility and efficiency between the two intelligent auto-registrations (based on hepatic vessels or based on liver surface) and manual registration for US-CT/MR fusion imaging of liver tumours. Methods From May 2017 to December 2017, 30 patients with 30 liver tumours were enrolled in this prospectively study. Two intelligent auto-registrations (based on hepatic vessels or based on liver surface) and manual registration were randomly performed, the registration success rate and efficiency were compared. Results In terms of success rate, auto-registrations based on the hepatic vessels (80%) was lower than auto-registration base on liver surface and manual registration (96.67%), but with no statistical difference (P = 0.125). In comparison of the registration efficiency, the efficiency of the auto-registration based on the hepatic vessels was superior to auto-registration based on liver surface and manual registration (P < 0.05). The one-step success rate of auto-registration based on the hepatic vessels (53.33%, 16/30) was higher than that of other two registrations (P < 0.05). Stratified analysis showed that, for the lesion with display of hepatic vessels in grade 3, the success rate of auto-registration based on vessels (0%) was lower than that of auto-registration based on liver surface and manual registration (100%) (P = 0.031). Conclusion Intelligent auto-registration based on hepatic vessels is a feasible and efficient registration method for US-CT/MR fusion imaging of liver tumours for the patients with clear hepatic vessels. The auto-registration based on liver surface and manual registration can be an effective supplement for cases with poor hepatic vessels display.
- 30 November 2024
- Published by Springer Nature in Abdominal Radiology
- Vol. 50 (6) , 2512-2521
Intelligent automatic registration: is it feasible and efficient for application of ultrasound fusion imaging in liver?
Purpose To evaluate the feasibility and efficiency between the two intelligent auto-registrations (based on hepatic vessels or based on liver surface) and manual registration for US-CT/MR fusion imaging of liver tumours. Methods From May 2017 to December 2017, 30 patients with 30 liver tumours were enrolled in this prospectively study. Two intelligent auto-registrations (based on hepatic vessels or based on liver surface) and manual registration were randomly performed, the registration success rate and efficiency were compared. Results In terms of success rate, auto-registrations based on the hepatic vessels (80%) was lower than auto-registration base on liver surface and manual registration (96.67%), but with no statistical difference (P = 0.125). In comparison of the registration efficiency, the efficiency of the auto-registration based on the hepatic vessels was superior to auto-registration based on liver surface and manual registration (P < 0.05). The one-step success rate of auto-registration based on the hepatic vessels (53.33%, 16/30) was higher than that of other two registrations (P < 0.05). Stratified analysis showed that, for the lesion with display of hepatic vessels in grade 3, the success rate of auto-registration based on vessels (0%) was lower than that of auto-registration based on liver surface and manual registration (100%) (P = 0.031). Conclusion Intelligent auto-registration based on hepatic vessels is a feasible and efficient registration method for US-CT/MR fusion imaging of liver tumours for the patients with clear hepatic vessels. The auto-registration based on liver surface and manual registration can be an effective supplement for cases with poor hepatic vessels display.
- 23 August 2024
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 97 (1163) , 1856-1862
Feasibility and safety study of ultrasound-guided percutaneous microwave ablation for sub-cardiac liver cancers without artificial ascites assistance
To investigate the efficacy and safety of ultrasound(US)-guided microwave ablation (MWA) without artificial ascites (AA) inpatients with sub-cardiac liver cancers. This retrospective study included patients with the left lobe and caudate lobe of the liver cancer who underwent US-guided MWA in our institute from January 2020 to December 2022. According to whether the target lesion was located ≤ 5 mm from the pericardium, patients were divided into the sub-cardiac (SC) group and the non-sub-cardiac (NSC) group. In the SC group, AA was not employed during the ablation procedure. The results of technical success, technical efficiency, local tumor progression (LTP), and major complications were recorded. A total of 79 patients with 87 lesions were enrolled. There were 38 patients with 38 lesions in the SC group and 41 patients with 49 lesions in the NSC group. The median follow-up of all patients was 15 (range, 3-44) months. There was no significant difference in technical success rates (100% versus 100%), technique efficiency rates (100% versus 95.7%), LTP rates (2.63% versus 0%,), and major complication rates (2.63% versus 7.32%) between the SC group and the NSC group (p > 0.05). No cardiac-related complications occurred. US-guided MWA without AA for sub-cardiac liver cancers was safe and effective. The clinical prognosis of thermal ablation without artificial ascites in the treatment of sub-cardiac liver cancers is still unclear. The finding of this study provided evidence supporting the efficacy and safety of ultrasound-guided microwave ablation without artificial ascites for treating this tricky location.
- 23 August 2024
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 97 (1163) , 1856-1862
Feasibility and safety study of ultrasound-guided percutaneous microwave ablation for sub-cardiac liver cancers without artificial ascites assistance
To investigate the efficacy and safety of ultrasound(US)-guided microwave ablation (MWA) without artificial ascites (AA) inpatients with sub-cardiac liver cancers. This retrospective study included patients with the left lobe and caudate lobe of the liver cancer who underwent US-guided MWA in our institute from January 2020 to December 2022. According to whether the target lesion was located ≤ 5 mm from the pericardium, patients were divided into the sub-cardiac (SC) group and the non-sub-cardiac (NSC) group. In the SC group, AA was not employed during the ablation procedure. The results of technical success, technical efficiency, local tumor progression (LTP), and major complications were recorded. A total of 79 patients with 87 lesions were enrolled. There were 38 patients with 38 lesions in the SC group and 41 patients with 49 lesions in the NSC group. The median follow-up of all patients was 15 (range, 3-44) months. There was no significant difference in technical success rates (100% versus 100%), technique efficiency rates (100% versus 95.7%), LTP rates (2.63% versus 0%,), and major complication rates (2.63% versus 7.32%) between the SC group and the NSC group (p > 0.05). No cardiac-related complications occurred. US-guided MWA without AA for sub-cardiac liver cancers was safe and effective. The clinical prognosis of thermal ablation without artificial ascites in the treatment of sub-cardiac liver cancers is still unclear. The finding of this study provided evidence supporting the efficacy and safety of ultrasound-guided microwave ablation without artificial ascites for treating this tricky location.
- 2 August 2024
- Published by Springer Nature in Abdominal Radiology
- Vol. 50 (1) , 400-408
Microwave ablation for colorectal liver metastases with ultrasound fusion imaging assistance: a stratified analysis study based on tumor size and location
Purpose To investigate the efficacy of ultrasound fusion imaging-assisted microwave ablation (MWA) for patients with colorectal liver metastases (CRLM) based on stratified analysis of tumor size and location. Methods Patients with CRLM who underwent ultrasound fusion imaging-assisted MWA in our hospital between February 2020 and February 2023 were enrolled into this retrospective study. Ultrasound fusion imaging was used for detection, guidance, monitoring and immediate evaluation throughout the MWA procedures. Technical success, technique efficacy, local tumor progression (LTP), intrahepatic progression and overall survival (OS) were recorded and analyzed. The subgroup analysis of intrahepatic progression of MWA for CRLM was performed according to tumor size and location. Results A total of 51 patients with 122 nodules were enrolled. Both technical success and technique efficacy were acquired in all nodules. In a median follow-up period of 19 months, 2.5% of the nodules (3/122) were observed LTP. The 1-year and 2-year cumulative intrahepatic progression rates were 38.7% and 52.1% respectively. Patients were divided into subgroups according to tumor size (≥ 30 mm, n = 13; < 30 mm, n = 38) and tumor location (perivascular, n = 20; non-perivascular, n = 31 and subcapsular, n = 36; non-subcapsular, n = 15). The cumulative intrahepatic progression rates were similar between the subgroups regarding tumor size and perivascular location, while significantly higher in the subcapsular group than in the non-subcapsular group (p = 0.021). Conclusion Ultrasound fusion imaging-assisted MWA exhibited satisfactory local efficacy for CRLM, especially for non-subcapsular tumors. Graphical Abstract
- 2 August 2024
- Published by Springer Nature in Abdominal Radiology
- Vol. 50 (1) , 400-408
Microwave ablation for colorectal liver metastases with ultrasound fusion imaging assistance: a stratified analysis study based on tumor size and location
Purpose To investigate the efficacy of ultrasound fusion imaging-assisted microwave ablation (MWA) for patients with colorectal liver metastases (CRLM) based on stratified analysis of tumor size and location. Methods Patients with CRLM who underwent ultrasound fusion imaging-assisted MWA in our hospital between February 2020 and February 2023 were enrolled into this retrospective study. Ultrasound fusion imaging was used for detection, guidance, monitoring and immediate evaluation throughout the MWA procedures. Technical success, technique efficacy, local tumor progression (LTP), intrahepatic progression and overall survival (OS) were recorded and analyzed. The subgroup analysis of intrahepatic progression of MWA for CRLM was performed according to tumor size and location. Results A total of 51 patients with 122 nodules were enrolled. Both technical success and technique efficacy were acquired in all nodules. In a median follow-up period of 19 months, 2.5% of the nodules (3/122) were observed LTP. The 1-year and 2-year cumulative intrahepatic progression rates were 38.7% and 52.1% respectively. Patients were divided into subgroups according to tumor size (≥ 30 mm, n = 13; < 30 mm, n = 38) and tumor location (perivascular, n = 20; non-perivascular, n = 31 and subcapsular, n = 36; non-subcapsular, n = 15). The cumulative intrahepatic progression rates were similar between the subgroups regarding tumor size and perivascular location, while significantly higher in the subcapsular group than in the non-subcapsular group (p = 0.021). Conclusion Ultrasound fusion imaging-assisted MWA exhibited satisfactory local efficacy for CRLM, especially for non-subcapsular tumors. Graphical Abstract
- Open Access
- 1 October 2023
- Published by Taylor & Francis in Journal of Hepatocellular Carcinoma
- Vol. ume 10, 1839-1848
Efficacy and Safety of Microwave Ablation Assisted by Ultrasound Fusion Imaging for Primary and Secondary Liver Cancers with a Diameter of 3–7 Cm
Purpose: To investigate the efficacy and safety of microwave ablation (MWA) assisted by ultrasound fusion imaging (FI) for primary and secondary liver cancers with a diameter of 3– 7 cm. Patients and Methods: A retrospective analysis was conducted on patients with primary and secondary liver cancers (3– 7 cm) who underwent MWA with ultrasound FI assistance in our hospital from April 2020 to May 2022. Technical success, technique efficacy, local tumor progression (LTP), major complication, intrahepatic distant recurrence (IDR), and overall survival (OS) were assessed during the follow-up period. In addition, the ablation results of tumors between the medium-sized group (3.1– 5.0 cm) and large-sized group (5.1– 7.0 cm) were compared. Results: 31 patients with 35 primary and secondary liver cancers were treated with MWA assisted by ultrasound FI. Complete ablation was achieved in 34 lesions with a technical success rate of 97.1%. Major complications occurred in 6.5% of patients (2/31), while no ablation-related deaths were reported. The median follow-up time of this study was 24 months (range:10 to 35 months). The technique efficacy rate was 97.1% (34/35), with LTP occurring in three lesions at a rate of 8.8% (3/34). The incidence of IDR was 38.7% (12/31) and the 2-year cumulative OS rate reached 96.7%. Moreover, there were no statistical differences in technique efficacy rate (p=0.286), LTP rate (p=0.328), major complication rate (p=0.503), IDR (p=0.857), and OS (p=0.118) between medium-sized group and large-sized group. Conclusion: Ultrasound FI-assisted MWA has the potential to be an effective and safe therapeutic strategy for primary and secondary liver cancers ranging from 3– 7 cm in size.
- 1 October 2023
- Published by Taylor & Francis in Journal of Hepatocellular Carcinoma
- Vol. ume 10, 1839-1848
Open AccessEfficacy and Safety of Microwave Ablation Assisted by Ultrasound Fusion Imaging for Primary and Secondary Liver Cancers with a Diameter of 3–7 Cm
Purpose: To investigate the efficacy and safety of microwave ablation (MWA) assisted by ultrasound fusion imaging (FI) for primary and secondary liver cancers with a diameter of 3– 7 cm. Patients and Methods: A retrospective analysis was conducted on patients with primary and secondary liver cancers (3– 7 cm) who underwent MWA with ultrasound FI assistance in our hospital from April 2020 to May 2022. Technical success, technique efficacy, local tumor progression (LTP), major complication, intrahepatic distant recurrence (IDR), and overall survival (OS) were assessed during the follow-up period. In addition, the ablation results of tumors between the medium-sized group (3.1– 5.0 cm) and large-sized group (5.1– 7.0 cm) were compared. Results: 31 patients with 35 primary and secondary liver cancers were treated with MWA assisted by ultrasound FI. Complete ablation was achieved in 34 lesions with a technical success rate of 97.1%. Major complications occurred in 6.5% of patients (2/31), while no ablation-related deaths were reported. The median follow-up time of this study was 24 months (range:10 to 35 months). The technique efficacy rate was 97.1% (34/35), with LTP occurring in three lesions at a rate of 8.8% (3/34). The incidence of IDR was 38.7% (12/31) and the 2-year cumulative OS rate reached 96.7%. Moreover, there were no statistical differences in technique efficacy rate (p=0.286), LTP rate (p=0.328), major complication rate (p=0.503), IDR (p=0.857), and OS (p=0.118) between medium-sized group and large-sized group. Conclusion: Ultrasound FI-assisted MWA has the potential to be an effective and safe therapeutic strategy for primary and secondary liver cancers ranging from 3– 7 cm in size.
- Open Access
- 2 August 2023
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 14, 1145958
Prediction of ablation zone disappearance after microwave ablation for the patients with papillary thyroid microcarcinoma using nomograph
Objectives: To construct a prognostic nomogram to predict the ablation zone disappearance for patients with papillary thyroid microcarcinoma (PTMC) after microwave ablation (MWA).Materials and methods: From April 2020 to April 2022, patients with PTMC who underwent MWA treatment were collected retrospectively. Ultrasound (US) or contrast-enhanced ultrasound (CEUS) was performed at 1 day, 1, 3, 6, 12, 18 and 24 months after MWA to observe the curative effect after ablation. The volume, volume reduction rate (VRR) and complete disappearance rate of the ablation zone at each time point were calculated. Univariate and multivariate logistic regression analysis were used to determine the prognostic factors associated with the disappearance of the ablation zone after MWA, and the nomogram was established and validated.Results: 72 patients with PTMCs underwent MWA were enrolled into this study. After MWA, no tumor progression (residual, recurrence or lymph node metastasis) and major postoperative complications occurred. The ablation zone in 28 (38.89%) patients did not completely disappear after MWA in the follow-up period. Three variables, including age (odds ratio [OR]: 1.216), calcification type (OR: 12.283), initial maximum diameter (OR: 2.051) were found to be independent prognostic factors predicting ablation zone status after MWA by multivariate analysis. The above variables and outcomes were visualized by nomogram (C-index=0.847).Conclusions: MWA was a safe and effective treatment for PTMC. Older patients with macrocalcification and larger size PTMCs were more unlikely to obtain complete disappearance of ablation zones. Incomplete disappearance of ablation zone was not related to recurrence.
- 2 August 2023
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 14, 1145958
Open AccessPrediction of ablation zone disappearance after microwave ablation for the patients with papillary thyroid microcarcinoma using nomograph
Objectives: To construct a prognostic nomogram to predict the ablation zone disappearance for patients with papillary thyroid microcarcinoma (PTMC) after microwave ablation (MWA).Materials and methods: From April 2020 to April 2022, patients with PTMC who underwent MWA treatment were collected retrospectively. Ultrasound (US) or contrast-enhanced ultrasound (CEUS) was performed at 1 day, 1, 3, 6, 12, 18 and 24 months after MWA to observe the curative effect after ablation. The volume, volume reduction rate (VRR) and complete disappearance rate of the ablation zone at each time point were calculated. Univariate and multivariate logistic regression analysis were used to determine the prognostic factors associated with the disappearance of the ablation zone after MWA, and the nomogram was established and validated.Results: 72 patients with PTMCs underwent MWA were enrolled into this study. After MWA, no tumor progression (residual, recurrence or lymph node metastasis) and major postoperative complications occurred. The ablation zone in 28 (38.89%) patients did not completely disappear after MWA in the follow-up period. Three variables, including age (odds ratio [OR]: 1.216), calcification type (OR: 12.283), initial maximum diameter (OR: 2.051) were found to be independent prognostic factors predicting ablation zone status after MWA by multivariate analysis. The above variables and outcomes were visualized by nomogram (C-index=0.847).Conclusions: MWA was a safe and effective treatment for PTMC. Older patients with macrocalcification and larger size PTMCs were more unlikely to obtain complete disappearance of ablation zones. Incomplete disappearance of ablation zone was not related to recurrence.